Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial

Abstract

Continuous infusion of meropenem is safe, in comparison with higher intermittent dosage provides equal clinical outcome, generates superior bacteriological efficacy and offers encouraging alternative of antimicrobial therapy in critically ill patients.

Keywords

• meropenem
• continuous infusion
• clinical outcome
• microbiological outcome